Abstract: Serine-based β-lactamases of Class A, C and D all rely on a key water molecule to hydrolyze and inactivate β-lactam antibiotics. This process involves two conserved catalytic steps. In the first acylation step, the β-lactam antibiotic forms an acyl-enzyme intermediate (ES) with the catalytic serine residue. In the second deacylation step, an activated water molecule serves as nucleophile (WAT_Nu) to attack ES and release the inactivated β-lactam. The coordination and activation of WAT_Nu is not fully understood. Using time-resolved x-ray crystallography and QM/MM simulations, we analyzed three intermediate structures of Class A β-lactamase PenP as it slowly hydrolyzed cephaloridine. WAT_Nu is centrally located in the apo structure but becomes slightly displaced away by ES in the post-acylation structure. In the deacylation structure, WAT_Nu moves back and is positioned along the Bürgi-Dunitz trajectory with favorable energetic profile to attack ES. Unexpectedly, WAT_Nu is also found to adopt a catalytically incompetent conformation in the deacylation structure forming a hydrogen bond with ES. Our results reveal that ES plays a significant role in coordinating and activating WAT_Nu through subtle yet distinct interactions at different stages of the catalytic process. These interactions may serve as potential targets to circumvent β-lactamase-mediated antibiotic resistance.
Introduction
Bacteria defend themselves against β-lactam antibiotics, such as penicillins and cephalosporins, using enzymes called β-lactamases. These enzymes function through a two-step mechanism: acylation, where the enzyme binds the antibiotic to form an acyl-enzyme intermediate (ES*), and deacylation, where a water molecule (WAT_Nu) attacks the intermediate to release the inactivated drug. While the general components of this reaction have been known for decades, the precise coordination and activation of the critical water molecule have remained elusive.
Capturing the "Attack" Conformation
To visualize this process in high resolution, researchers utilized a "slow-motion" mutant of the Class A β-lactamase PenP (Glu166Tyr). By replacing a key glutamate residue with tyrosine, the team slowed the deacylation step sufficiently to capture snapshots of the reaction using time-resolved X-ray crystallography at 1, 3, and 6 seconds during the hydrolysis of cephaloridine.
These structural snapshots were complemented by Quantum Mechanics/Molecular Mechanics (QM/MM) simulations. This dual approach allowed the team to model electronic changes in the active site with high precision while calculating the energy barriers associated with different molecular conformations.
Key Insights: The Dynamic Water Molecule
The study revealed that WAT_Nu is not static. In the enzyme's "apo" (unbound) state, the water molecule sits centrally. Upon acylation, the binding drug pushes the water molecule away by approximately 1.2 Å. During the deacylation phase, however, the water moves back into a precise "attack" position.
Crucially, the ES* intermediate acts as a guide rather than a passive bystander. It forms a hydrogen bond network that tethers the water molecule into the mathematically optimal angle for nucleophilic attack, known as the Bürgi-Dunitz trajectory (~100°). This is the first time this trajectory has been clearly visualized in this class of enzyme.
Results and the "Tilted" Trap
Kinetic analysis of the Glu166Tyr mutant showed a 20-fold reduction in catalytic efficiency ($k_{cat}/K_M$), which facilitated the time-resolved structural studies. The QM/MM simulations confirmed that the observed "attack" conformation has a potential energy barrier of ~22.8 kcal/mol, aligning with experimental reaction rates.
One of the most significant findings was the identification of a second, "incompetent" conformation. If the antibiotic's carbonyl group tilts slightly, it forms a strong hydrogen bond with the water molecule, effectively "locking" it in a position where it cannot perform the attack. This "tilted" state presents a massive energy barrier (~50 kcal/mol), stalling the enzyme's activity.
Implications for Drug Design
The discovery of this incompetent conformation provides a new structural target for antibiotic development. By designing "suicide inhibitors" or new antibiotics that intentionally trigger this "tilted" state, researchers may be able to neutralize β-lactamases and restore the efficacy of existing antibiotic treatments against resistant bacterial strains.
Summary updated